Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.Sandra M. Swain, Richard A. Gams, Fredrick S. Whaley et al.|Journal of Clinical Oncology|1997Cited by 652
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast CancerSylvia Adams, Sandra Demaria, Lina Kozhaya et al.|Clinical Cancer Research|2012Cited by 225
Interferon α-2a and Dacarbazine in MelanomaJohn M. Kirkwood, Robert J. Spiegel, P Pouillart et al.|JNCI Journal of the National Cancer Institute|1990Cited by 47
Supplementary Figure 1 from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast CancerSylvia Adams, Sandra Demaria, Lina Kozhaya et al.|Unknown|2023Cited by 0
Supplementary Figure Legend from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast CancerSylvia Adams, Sandra Demaria, Lina Kozhaya et al.|Unknown|2023Cited by 0